Symbol="XBIOW"
AssetType="Common Stock"
Name="Xenetic Biosciences Inc"
Description="Xenetic Biosciences, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, research, and development of next-generation biologics and novel orphan cancer therapies. The company is headquartered in Framingham, Massachusetts."
CIK="1534525"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="40 SPEEN STREET, SUITE 102, FRAMINGHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="None"
EBITDA="None"
PERatio="None"
PEGRatio="None"
BookValue="None"
DividendPerShare="None"
DividendYield="0"
EPS="None"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="0"
ReturnOnEquityTTM="0"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="0"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-"
Beta="None"
num_52WeekHigh="23.16"
num_52WeekLow="0.001"
num_50DayMovingAverage="6.97"
num_200DayMovingAverage="2.454"
SharesOutstanding="0"
DividendDate="None"
ExDividendDate="None"
symbol="XBIOW"
open="9.04"
high="9.04"
low="9.04"
price="9.04"
volume="11.00"
latest_trading_day="2023-07-21"
previous_close="10.34"
change="-1.30"
change_percent="-12.5725%"
aroon_positive_momentum_days="81"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="81"
Volume_recent_avg="727"
Change_recent_avg="0.04"
Delta_recent_avg="0.19"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="1.23"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_60"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="81"
Aroon_momentum_negative="19"
image_negative_thumbnail_id_1="167"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0009.jpeg"
image_negative_thumbnail_id_2="1140"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0173.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="523"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_positive_thumbnail_id_1="985"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0147.jpeg"
image_positive_thumbnail_id_2="1001"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0163.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1177"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
